Original Research
Accepted on 24 Feb 2025
Zanubrutinib plus CHOP improves the treatment effect of newly diagnosed diffuse large B cell lymphoma with double expression of MYC and BCL-2
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 24 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 24 Feb 2025
in PET and SPECT
Original Research
Accepted on 24 Feb 2025
in Brain Imaging Methods
Opinion
Accepted on 24 Feb 2025
in Oral Health Promotion
Brief Research Report
Accepted on 24 Feb 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 24 Feb 2025
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 24 Feb 2025
in Viral Immunology
Review
Accepted on 24 Feb 2025
in Ethnopharmacology
Original Research
Accepted on 24 Feb 2025
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 24 Feb 2025
in Computational Genomics
Editorial
Accepted on 24 Feb 2025
in Mucosal Immunity
Original Research
Accepted on 24 Feb 2025
in Infectious Diseases: Epidemiology and Prevention
Original Research
Accepted on 24 Feb 2025
in Environmental Informatics and Remote Sensing
Original Research
Accepted on 24 Feb 2025
in Social-Ecological Urban Systems
Review
Accepted on 24 Feb 2025
in Health Technology Implementation
Original Research
Accepted on 24 Feb 2025
in Hematologic Malignancies